{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "San Juan",
      "state": "PR",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "63608",
      "recalling_firm": "Alara Pharmaceutical Co",
      "address_1": "270 Ave Munoz Rivera #301",
      "address_2": "N/A",
      "postal_code": "00918",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-104-2013",
      "product_description": "Levothyroxine Sodium Tablets, USP, 175 mcg in 90 ct bottles, Manufactured by Patheon Puerto Rico Inc., for Alara Pharmaceutical Corp, San Juan, PR",
      "product_quantity": "7,432 bottles",
      "reason_for_recall": "Subpotent; 15 month stability",
      "recall_initiation_date": "20121029",
      "center_classification_date": "20121221",
      "termination_date": "20140103",
      "report_date": "20130102",
      "code_info": "11T7011A, Exp. Date: 12/2012"
    }
  ]
}